Two Drugs Allowed By FDA for ‘Compassionate Use’ to Treat the Coronavirus

March 24, 2020 Updated: March 24, 2020

Two drugs have been approved for Expanded Access, or “compassionate use”, by the U.S. Food and Drug Administration (FDA) to treat COVID-19, the disease caused by the CCP virus. What are they and how do they work? Why should the virus be referred to as the CCP virus?

In this episode of Zooming In, Simone Gao discusses these questions with Dr. Sean Lin, former lab director of the Viral Disease Branch, Walter Reed Army Institute of Research.

Subscribe for updates on YouTube and follow us on Facebook.

Official website: https://www.ntd.com/zooming-in

Follow Simone on Twitter: @ZoomingIn_NTD.

Download our new podcast, now available on iTunes, Spotify, and Google.